CD8 epitope from HIV-1 protein Vpu
US7022325B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 27, 2002 |
| Grant date | Apr 4, 2006 |
| Priority date | — |
| Expiry date | Sep 27, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16322
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the identification and the selection of CTL epitopes able to induce a protection against an HIV infection. More particularly, the invention is concerned with peptides and nucleic acid sequence coding for these peptides derived from HIV-1 proteins such as GAG, POL, ENV, VIF, TAT, VPU, REV and their applications. Preferably the immunogenic peptides are selected from the group consisting of SEQ ID NOs:1 to 18 and functional derivatives thereof. The invention also relates to antibodies directed against said peptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.